Cargando…
Hydrogel systems for targeted cancer therapy
When hydrogel materials with excellent biocompatibility and biodegradability are used as excellent new drug carriers in the treatment of cancer, they confer the following three advantages. First, hydrogel materials can be used as a precise and controlled drug release systems, which can continuously...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977812/ https://www.ncbi.nlm.nih.gov/pubmed/36873346 http://dx.doi.org/10.3389/fbioe.2023.1140436 |
_version_ | 1784899376416555008 |
---|---|
author | Li, Xinlin Xu, Xinyi Xu, Mengfei Geng, Zhaoli Ji, Ping Liu, Yi |
author_facet | Li, Xinlin Xu, Xinyi Xu, Mengfei Geng, Zhaoli Ji, Ping Liu, Yi |
author_sort | Li, Xinlin |
collection | PubMed |
description | When hydrogel materials with excellent biocompatibility and biodegradability are used as excellent new drug carriers in the treatment of cancer, they confer the following three advantages. First, hydrogel materials can be used as a precise and controlled drug release systems, which can continuously and sequentially release chemotherapeutic drugs, radionuclides, immunosuppressants, hyperthermia agents, phototherapy agents and other substances and are widely used in the treatment of cancer through radiotherapy, chemotherapy, immunotherapy, hyperthermia, photodynamic therapy and photothermal therapy. Second, hydrogel materials have multiple sizes and multiple delivery routes, which can be targeted to different locations and types of cancer. This greatly improves the targeting of drugs, thereby reducing the dose of drugs and improving treatment effectiveness. Finally, hydrogel can intelligently respond to environmental changes according to internal and external environmental stimuli so that anti-cancer active substances can be remotely controlled and released on demand. Combining the abovementioned advantages, hydrogel materials have transformed into a hit in the field of cancer treatment, bringing hope to further increase the survival rate and quality of life of patients with cancer. |
format | Online Article Text |
id | pubmed-9977812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99778122023-03-03 Hydrogel systems for targeted cancer therapy Li, Xinlin Xu, Xinyi Xu, Mengfei Geng, Zhaoli Ji, Ping Liu, Yi Front Bioeng Biotechnol Bioengineering and Biotechnology When hydrogel materials with excellent biocompatibility and biodegradability are used as excellent new drug carriers in the treatment of cancer, they confer the following three advantages. First, hydrogel materials can be used as a precise and controlled drug release systems, which can continuously and sequentially release chemotherapeutic drugs, radionuclides, immunosuppressants, hyperthermia agents, phototherapy agents and other substances and are widely used in the treatment of cancer through radiotherapy, chemotherapy, immunotherapy, hyperthermia, photodynamic therapy and photothermal therapy. Second, hydrogel materials have multiple sizes and multiple delivery routes, which can be targeted to different locations and types of cancer. This greatly improves the targeting of drugs, thereby reducing the dose of drugs and improving treatment effectiveness. Finally, hydrogel can intelligently respond to environmental changes according to internal and external environmental stimuli so that anti-cancer active substances can be remotely controlled and released on demand. Combining the abovementioned advantages, hydrogel materials have transformed into a hit in the field of cancer treatment, bringing hope to further increase the survival rate and quality of life of patients with cancer. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9977812/ /pubmed/36873346 http://dx.doi.org/10.3389/fbioe.2023.1140436 Text en Copyright © 2023 Li, Xu, Xu, Geng, Ji and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Li, Xinlin Xu, Xinyi Xu, Mengfei Geng, Zhaoli Ji, Ping Liu, Yi Hydrogel systems for targeted cancer therapy |
title | Hydrogel systems for targeted cancer therapy |
title_full | Hydrogel systems for targeted cancer therapy |
title_fullStr | Hydrogel systems for targeted cancer therapy |
title_full_unstemmed | Hydrogel systems for targeted cancer therapy |
title_short | Hydrogel systems for targeted cancer therapy |
title_sort | hydrogel systems for targeted cancer therapy |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977812/ https://www.ncbi.nlm.nih.gov/pubmed/36873346 http://dx.doi.org/10.3389/fbioe.2023.1140436 |
work_keys_str_mv | AT lixinlin hydrogelsystemsfortargetedcancertherapy AT xuxinyi hydrogelsystemsfortargetedcancertherapy AT xumengfei hydrogelsystemsfortargetedcancertherapy AT gengzhaoli hydrogelsystemsfortargetedcancertherapy AT jiping hydrogelsystemsfortargetedcancertherapy AT liuyi hydrogelsystemsfortargetedcancertherapy |